Stengone Carmine N. Insider Trades

Insider Trading History

Track insider trading activity for Stengone Carmine N.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Contineum Therapeutics
Contineum Therapeutics CTNM
CEO And President
Holding Value $1.49M 120,917 shares
Last Trade
Feb 25, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42.6k 2,700 shares
$15.78
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
CEO And President
Holding Value $218k 17,654 shares
Last Trade
Feb 25, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42.6k 2,700 shares
$15.78
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
CEO And President
Holding Value $185k 14,954 shares
Last Trade
Feb 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$43.3k 2,700 shares
$16.02
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
CEO And President
Holding Value $1.53M 123,617 shares
Last Trade
Feb 24, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$70.1k 4,400 shares
$15.93
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
CEO And President
Holding Value $239k 19,354 shares
Last Trade
Feb 24, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$70.1k 4,400 shares
$15.93
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
CEO And President
Holding Value $185k 14,954 shares
Last Trade
Feb 24, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$70.5k 4,400 shares
$16.02
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
CEO And President
Holding Value $189k 15,354 shares
Last Trade
Feb 11, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.1k 400 shares
$15.26
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
CEO And President
Holding Value $1.58M 128,017 shares
Last Trade
Feb 11, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.1k 400 shares
$15.26
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
CEO And President
Holding Value $185k 14,954 shares
Last Trade
Feb 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.4k 400 shares
$16.00
$12.34
Contineum Therapeutics
Contineum Therapeutics CTNM
CEO And President
Holding Value $5.49M 445,000 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.35M 445,000 shares
$14.26
$12.34
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Director
Holding Value $52.6k 20,000 shares
Last Trade
Apr 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$58.6k 20,000 shares
$2.93
$2.63
Contineum Therapeutics
Contineum Therapeutics CTNM
CEO And President
Holding Value $3.7M 300,000 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.94M 300,000 shares
$9.79
$12.34
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Director
Holding Value $3.29k 1,250 shares
Last Trade
Sep 11, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.6k 1,250 shares
$3.68
$2.63
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Director
Holding Value $4.68k 1,778 shares
Last Trade
Jul 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.73k 1,778 shares
$4.35
$2.63
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Director
Holding Value $21k 8,000 shares
Last Trade
Sep 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40.9k 8,000 shares
$5.11
$2.63

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up